Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 21

    1.

    Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).

    Pop-Busui R, Lombardero M, Lavis V, Forker A, Green J, Korytkowski M, Sobel BE, Jones TL; BARI 2D Study Group.

    Am J Cardiol. 2009 Jul 1;104(1):52-8. Epub 2009 May 13.PMID: 19576321 [PubMed - indexed for MEDLINE]Related articles

    2.

    The role of the endogenous opioid system in polycystic ovary syndrome.

    Eyvazzadeh AD, Pennington KP, Pop-Busui R, Sowers M, Zubieta JK, Smith YR.

    Fertil Steril. 2009 Jul;92(1):1-12. Review.PMID: 19560572 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).

    Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH; DCCT/EDIC Research Group.

    Circulation. 2009 Jun 9;119(22):2886-93. Epub 2009 May 26.PMID: 19470886 [PubMed - in process]Related articles

    4.

    Elevated triglycerides correlate with progression of diabetic neuropathy.

    Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL.

    Diabetes. 2009 Jul;58(7):1634-40. Epub 2009 May 1.PMID: 19411614 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus.

    Pop-Busui R, Oral E, Raffel D, Byun J, Bajirovic V, Vivekanandan-Giri A, Kellogg A, Pennathur S, Stevens MJ.

    Metabolism. 2009 Jul;58(7):989-94.PMID: 19394661 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.

    Pop-Busui R, Lu J, Lopes N, Jones TL; BARI 2D Investigators.

    J Peripher Nerv Syst. 2009 Mar;14(1):1-13.PMID: 19335534 [PubMed - indexed for MEDLINE]Related articles

    7.

    Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

    Pambianco G, Lombardero M, Bittner V, Forker A, Kennedy F, Krishnaswami A, Mooradian AD, Pop-Busui R, Rana JS, Rodriguez A, Steffes M, Orchard TJ.

    Prev Cardiol. 2009 Winter;12(1):9-18.PMID: 19301686 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes.

    Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R.

    Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H453-61. Epub 2008 Dec 5.PMID: 19060127 [PubMed - indexed for MEDLINE]Related articles

    9.

    Thiazolidinediones in type 2 diabetes: a cardiology perspective.

    Khanderia U, Pop-Busui R, Eagle KA.

    Ann Pharmacother. 2008 Oct;42(10):1466-74. Epub 2008 Sep 2. Review.PMID: 18698014 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rapid, noninvasive detection of diabetes-induced retinal metabolic stress.

    Field MG, Elner VM, Puro DG, Feuerman JM, Musch DC, Pop-Busui R, Hackel R, Heckenlively JR, Petty HR.

    Arch Ophthalmol. 2008 Jul;126(7):934-8.PMID: 18625939 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy.

    Kellogg AP, Cheng HT, Pop-Busui R.

    Curr Drug Targets. 2008 Jan;9(1):68-76. Review.PMID: 18220714 [PubMed - indexed for MEDLINE]Related articles

    12.

    Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes.

    Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R.

    Diabetes. 2007 Dec;56(12):2997-3005. Epub 2007 Aug 24.PMID: 17720896 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?

    Albers JW, Herman WH, Pop-Busui R, Martin CL, Cleary P, Waberski B; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group.

    Diabetes Care. 2007 Oct;30(10):2613-8. Epub 2007 Jul 20.PMID: 17644617 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Does lamotrigine alleviate the pain in diabetic neuropathy?

    Pop-Busui R.

    Nat Clin Pract Neurol. 2007 Aug;3(8):424-5. Epub 2007 Jun 12. No abstract available. PMID: 17563772 [PubMed]Related articles

    15.

    Diabetic neuropathy and oxidative stress.

    Pop-Busui R, Sima A, Stevens M.

    Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):257-73. Review.PMID: 16506271 [PubMed - indexed for MEDLINE]Related articles

    16.

    Regulation of the human taurine transporter by oxidative stress in retinal pigment epithelial cells stably transformed to overexpress aldose reductase.

    Nakashima E, Pop-Busui R, Towns R, Thomas TP, Hosaka Y, Nakamura J, Greene DA, Killen PD, Schroeder J, Larkin DD, Ho YL, Stevens MJ.

    Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1530-42.PMID: 16356117 [PubMed - indexed for MEDLINE]Related articles

    17.

    Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress.

    Kellogg AP, Pop-Busui R.

    Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1521-9.PMID: 16356116 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.

    Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D, Yamada E, Raffel DM, Stevens MJ.

    J Am Coll Cardiol. 2004 Dec 21;44(12):2368-74.PMID: 15607400 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.

    Pop-Busui R, Marinescu V, Van Huysen C, Li F, Sullivan K, Greene DA, Larkin D, Stevens MJ.

    Diabetes. 2002 Aug;51(8):2619-28.PMID: 12145179 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.

    Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.

    Exp Neurol. 2001 Apr;168(2):259-72.PMID: 11259114 [PubMed - indexed for MEDLINE]Related articles

    21.

    Severe hypertension induced by the long-acting somatostatin analogue sandostatin LAR in a patient with diabetic autonomic neuropathy.

    Pop-Busui R, Chey W, Stevens MJ.

    J Clin Endocrinol Metab. 2000 Mar;85(3):943-6.PMID: 10720019 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...